Rosenblum Mark J
- SEC CIK
- 0001329154
In the past year, 1 open-market purchase filing worth $16.0K and no sales.
Current role at each company
- DCOY Decoy Therapeutics Inc.Chief Financial Officeras of Sep 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $16.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$16.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Rosenblum Mark J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 (view filing) | Nov 20 | Same day | Rosenblum Mark JExec VP Finance, CFO | PPurchase | +20.0K | $0.80 | +$16.0K | +11,299.4%20.2K after | |
| May 31, 2022 (view filing)5:13 PM ET | May 31 | Same day | Rosenblum Mark JExec VP Finance, CFO | PPurchase | +28.0K | $0.18 | +$5.04K | +23.3%148.3K after | |
| Mar 9, 2022 (view filing)4:03 PM ET | Mar 3 | 6 daysLate | Rosenblum Mark JExec VP Finance, CFO | PPurchase | +76.2K | $0.391 | +$29.8K | +223.8%110.3K after |